| Title: |
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial |
| Authors: |
Blay, Jean-Yves; Chevret, Sylvie; Le Cesne, Axel; Brahmi, Mehdi; Penel, Nicolas; Cousin, Sophie; Bertucci, Francois; Bompas, Emmanuelle; Ryckewaert, Thomas; Soibinet, Pauline; Boudou-Rouquette, Pascaline; Saada Bouzid, Esma; Soulie, Patrick; Valentin, Thibaud; Lotz, Jean-Pierre; Tosi, Diego; Neviere, Zoé; Cancel, Mathilde; Ray-Coquard, Isabelle; Gambotti, Laetitia; Legrand, Frédéric; Lamrani-Ghaouti, Assia; Simon, Clotilde; Even, Caroline; Massard, Christophe |
| Source: |
The Lancet Oncology ; volume 24, issue 8, page 892-902 ; ISSN 1470-2045 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2023 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/s1470-2045(23)00282-6 |
| Availability: |
http://dx.doi.org/10.1016/s1470-2045(23)00282-6; https://api.elsevier.com/content/article/PII:S1470204523002826?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S1470204523002826?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ ; https://doi.org/10.15223/policy-017 ; https://doi.org/10.15223/policy-037 ; https://doi.org/10.15223/policy-012 ; https://doi.org/10.15223/policy-029 ; https://doi.org/10.15223/policy-004 |
| Accession Number: |
edsbas.2BD3E0F3 |
| Database: |
BASE |